A phase IIa study of prolonged use of cannabidiol in the prevention of Graft versus Host Disease
Phase of Trial: Phase II
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Cannabidiol (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Sponsors TALENT Biotech
- 16 Feb 2017 Results published in a Kalytera Therapeutics media release.
- 03 Feb 2017 New trial record
- 18 Jan 2017 Preliminary results published in a Kalytera Therapeutics media release.